Record ID | marc_columbia/Columbia-extract-20221130-014.mrc:10961116:2935 |
Source | marc_columbia |
Download Link | /show-records/marc_columbia/Columbia-extract-20221130-014.mrc:10961116:2935?format=raw |
LEADER: 02935cam a22005054a 4500
001 6601566
005 20221122041019.0
008 080116s2008 nyu b 001 0 eng
010 $a 2008002097
020 $a9780374228279 (hardcover : alk. paper)
020 $a0374228272 (hardcover : alk. paper)
024 $a40015259488
035 $a(OCoLC)ocn166378206
035 $a(OCoLC)166378206
035 $a(NNC)6601566
035 $a6601566
040 $aDNLM/DLC$cDLC$dNLM$dBTCTA$dBAKER$dYDXCP$dUPZ$dC#P$dOrLoB-B
042 $apcc
043 $an-us---
050 00 $aHD9666.5$b.P415 2008
060 10 $aQV 736$bP484o 2008
082 00 $a338.4/761510973$222
100 1 $aPetersen, Melody,$d1964-$0http://id.loc.gov/authorities/names/n2008180224
245 10 $aOur daily meds :$bhow the pharmaceutical companies transformed themselves into slick marketing machines and hooked the nation on prescription drugs /$cMelody Petersen.
250 $a1st ed.
260 $aNew York :$bFarrar, Straus and Giroux,$c2008.
300 $a432 pages ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
505 00 $gPt. I.$tRx Republic -- $g1.$tCreating Disease -- $g2.$tMidwestern Medicine Show -- $g3.$tChemical Imbalance -- $gPt. II.$tThe Rise of the Medicine Merchants -- $g4.$tThe Early Years -- $g5.$tAn Awakening: The Age of the Blockbuster -- $g6.$tGhostwriters and Secret Studies -- $g7.$t"Neurontin for Everything" -- $gPt. III.$tA Bitter Pill -- $g8.$tAltered State -- $g9.$tDeadly Doses.
500 $a"Sarah Crichton books."
504 $aIncludes bibliographical references (p. [409]-411) and index.
520 1 $a"In Our Daily Meds, Melody Petersen argues that corporate salesmanship has triumphed over science inside the biggest pharmaceutical companies and, in turn, how this promotion-driven industry has taken over the practice of medicine and is changing American life."--BOOK JACKET.
650 0 $aDrugs$zUnited States$xMarketing.$0http://id.loc.gov/authorities/subjects/sh2009123359
650 12 $aDrug Industry$xeconomics.$0https://id.nlm.nih.gov/mesh/D004345Q000191
650 12 $aDrug Industry$xethics.$0https://id.nlm.nih.gov/mesh/D004345Q000941
650 22 $aBiomedical Research$xeconomics.$0https://id.nlm.nih.gov/mesh/D035843Q000191
650 22 $aMarketing$xethics.$0https://id.nlm.nih.gov/mesh/D040541Q000941
650 22 $aPractice Patterns, Physicians'$xethics.$0https://id.nlm.nih.gov/mesh/D010818Q000941
650 22 $aDrug Prescriptions$xeconomics.$0https://id.nlm.nih.gov/mesh/D011307Q000191
651 2 $aUnited States.$0https://id.nlm.nih.gov/mesh/D014481
856 42 $3Contributor biographical information$uhttp://www.loc.gov/catdir/enhancements/fy0809/2008002097-b.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0809/2008002097-d.html
852 00 $boff,bus$hHD9666.5$i.P415 2008
852 00 $bbar$hHD9666.5$i.P415 2008